AstraZeneca cans late-stage Ultomiris trial on lacklustre efficacy predictions
AstraZeneca has opted to terminate a late-stage trial evaluating Ultomiris (ravulizumab) in treating a common complication of kidney transplantation, dashing…
News
Geron winds down Phase III rare blood cancer trial after muted efficacy
Starton and Stanford to study STAR-LLD combination in MM
Nuvation Bio to broaden Phase III glioma trial into Europe
Genmab’s bispecific halves risk of death in first-line HNSCC
Sobi’s gout drug shows durability in Phase III study
United Therapeutics secures FDA clearance for PAH Phase I trial
First patient dosed in Nacuity’s Phase III Usher syndrome RP trial
